HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NDUFA6
NADH:ubiquinone oxidoreductase subunit A6
Chromosome 22 Β· 22q13.2
NCBI Gene: 4700Ensembl: ENSG00000184983.11HGNC: HGNC:7690UniProt: A0A2Y9D025
65PubMed Papers
21Diseases
3Drugs
5Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneTransporter
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
respiratory chain complex Imitochondrial respiratory chain complex I assemblymitochondrial inner membranemitochondrionmitochondrial complex I deficiency, nuclear type 33type 2 diabetes mellitusdiabetes mellitusmitochondrial complex I deficiency
✦AI Summary

NDUFA6 encodes a 15 kDa accessory subunit of mitochondrial respiratory complex I that is essential for proper complex assembly and function 1. As part of the Q-module, NDUFA6 is required for incorporating other Q-module subunits including NDUFAB1, NDUFA7, and NDUFA12 into the complex, though it does not directly participate in catalysis 1. The protein functions in electron transfer from NADH to ubiquinone and contributes to mitochondrial ATP synthesis. Bi-allelic mutations in NDUFA6 cause early-onset isolated mitochondrial complex I deficiency, presenting with neurological symptoms and elevated lactate levels 1. Beyond its structural role, NDUFA6 serves as a regulatory target - ceramide binding to NDUFA6 can inactivate complex I to reduce oxidative stress in liver ischemia/reperfusion injury 2. The gene also has broader clinical significance, with elevated NDUFA6 expression associated with poor prognosis in acute myeloid leukemia and multiple myeloma 34. Additionally, a missense variant (rs1801311) in NDUFA6 confers schizophrenia risk by affecting transcription factor binding and regulating distant gene expression 5. Gene therapy with NDUFA6 has shown therapeutic potential in treating neurodegeneration in experimental models 6.

Sources cited
1
NDUFA6 is a 15 kDa Q-module subunit required for complex I assembly and incorporation of other Q-module subunits
PMID: 30245030
2
Ceramide binding to NDUFA6 inactivates complex I and reduces oxidative stress in liver injury
PMID: 40244698
3
Elevated NDUFA6 expression is associated with poor overall survival in AML patients
PMID: 39533394
4
Higher NDUFA6 expression correlates with worse prognosis in multiple myeloma patients
PMID: 36551283
5
Missense variant rs1801311 in NDUFA6 confers schizophrenia risk by affecting transcription factor binding
PMID: 33931730
6
NDUFA6 gene therapy rescued complex I activity and prevented neurodegeneration in EAE model
PMID: 25613946
Disease Associationsβ“˜21
mitochondrial complex I deficiency, nuclear type 33Open Targets
0.72Strong
type 2 diabetes mellitusOpen Targets
0.61Moderate
diabetes mellitusOpen Targets
0.60Moderate
mitochondrial complex I deficiencyOpen Targets
0.59Moderate
neurodegenerative diseaseOpen Targets
0.57Moderate
mitochondrial diseaseOpen Targets
0.54Moderate
Parkinson diseaseOpen Targets
0.54Moderate
multiple sclerosisOpen Targets
0.49Moderate
Alzheimer diseaseOpen Targets
0.46Moderate
lysosomal storage diseaseOpen Targets
0.46Moderate
polycystic ovary syndromeOpen Targets
0.41Moderate
gestational diabetesOpen Targets
0.41Moderate
Insulin resistanceOpen Targets
0.40Moderate
obesityOpen Targets
0.40Moderate
prediabetes syndromeOpen Targets
0.40Weak
metabolic syndromeOpen Targets
0.39Weak
type 1 diabetes mellitusOpen Targets
0.39Weak
Disorder of lipid metabolismOpen Targets
0.38Weak
genetic disorderOpen Targets
0.37Weak
agingOpen Targets
0.37Weak
Mitochondrial complex I deficiency, nuclear type 33UniProt
Pathogenic Variants5
NM_002490.6(NDUFA6):c.309del (p.Met104fs)Likely pathogenic
Mitochondrial complex I deficiency, nuclear type 33|Mitochondrial disease|Inborn genetic diseases|NDUFA6-related disorder
β˜…β˜†β˜†β˜†2022β†’ Residue 104
NM_002490.6(NDUFA6):c.331_332del (p.Glu111fs)Pathogenic
Mitochondrial disease|Mitochondrial complex I deficiency, nuclear type 33
β˜†β˜†β˜†β˜†2018β†’ Residue 111
NM_002490.6(NDUFA6):c.265G>T (p.Glu89Ter)Pathogenic
Mitochondrial disease|Mitochondrial complex I deficiency, nuclear type 33
β˜†β˜†β˜†β˜†2018β†’ Residue 89
NM_002490.6(NDUFA6):c.191G>C (p.Arg64Pro)Pathogenic
Mitochondrial disease|Mitochondrial complex I deficiency, nuclear type 33
β˜†β˜†β˜†β˜†2018β†’ Residue 64
NM_002490.6(NDUFA6):c.355del (p.Leu119fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 33|Mitochondrial disease
β˜†β˜†β˜†β˜†2018β†’ Residue 119
View on ClinVar β†—
Drug Targets3
ME-344Phase I/II
Mitochondrial complex I (NADH dehydrogenase) inhibitor
breast cancer
METFORMINApproved
Mitochondrial complex I (NADH dehydrogenase) inhibitor
diabetes mellitus
METFORMIN HYDROCHLORIDEApproved
Mitochondrial complex I (NADH dehydrogenase) inhibitor
type 2 diabetes mellitus
Related Genes
NDUFS8Protein interaction100%NDUFS5Protein interaction100%ATP5MEProtein interaction100%ATP5PFProtein interaction100%BLVRBProtein interaction100%COX5BProtein interaction100%
Tissue Expression6 tissues
Heart
100%
Brain
34%
Liver
29%
Bone Marrow
18%
Lung
18%
Ovary
12%
Gene Interaction Network
Click a node to explore
NDUFA6NDUFS8NDUFS5ATP5MEATP5PFBLVRBCOX5B
PROTEIN STRUCTURE
Preparing viewer…
PDB5XTB Β· 3.40 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.52LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.88 [0.53–1.52]
RankingsWhere NDUFA6 stands among ~20K protein-coding genes
  • #7,188of 20,598
    Most Researched65
  • #633of 1,025
    FDA-Approved Drug Targets2
  • #3,559of 5,498
    Most Pathogenic Variants5
  • #15,294of 17,882
    Most Constrained (LOEUF)1.52
Genes detectedNDUFA6
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Ceramide(d18:1/18:1)-NDUFA6 interaction inactivates respiratory complex I to attenuate oxidative-stress-driven pathogenesis in liver ischemia/reperfusion injury.
PMID: 40244698
JCI Insight Β· 2025
1.00
2
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine.
PMID: 39533394
World J Surg Oncol Β· 2024
0.90
3
LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
PMID: 38674418
Genes (Basel) Β· 2024
0.80
4
Bi-allelic Mutations in NDUFA6 Establish Its Role in Early-Onset Isolated Mitochondrial Complex I Deficiency.
PMID: 30245030
Am J Hum Genet Β· 2018
0.70
5
A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression.
PMID: 33931730
Mol Psychiatry Β· 2021
0.60